English | 中文 | Español

N-(Methoxycarbonyl)-L-tert-leucine

CAS No.:162537-11-3
Product Grade: Pharmaceutical Grade
Purity / Assay: 98%
Molecular Formula:C₈H₁₅NO₄
Molecular Weight:189.21
Synonym(s):MOC-L-tert-Leucine; Methoxycarbonyl-L-tert-leucine; Atazanavir Related Compound A

N-(Methoxycarbonyl)-L-tert-leucine (CAS: 162537-11-3) is a white crystalline chiral amino acid derivative combining an L-tert-leucine core with a methoxycarbonyl-protected amine. It is a key intermediate for the efficient synthesis of HIV protease inhibitors, most notably atazanavir, where the bulky tert-butyl side chain and protected amine are built into the active structure. The compound also serves as a reference material for atazanavir related-compound analysis. Material is controlled for enantiomeric consistency to support asymmetric API synthesis. Customers procure it for antiretroviral API programs where consistent stereochemical quality is essential.

• Protease inhibitor intermediate: a key chiral building block for atazanavir and related HIV protease inhibitors.

• Protected amine: the methoxycarbonyl group and tert-leucine core are incorporated directly into API structures.

• Impurity reference: serves as atazanavir related compound A for analytical impurity profiling.

• Chiral quality: specified by chemical and enantiomeric purity for asymmetric API synthesis.

25kg/drum, 200kg/drum
CAS No.: 162537-11-3

Product Name: N-(Methoxycarbonyl)-L-tert-leucine

Purity / Assay:98%
Molecular Formula:C₈H₁₅NO₄
Molecular Weight:189.21
Synonym(s):MOC-L-tert-Leucine; Methoxycarbonyl-L-tert-leucine; Atazanavir Related Compound A

N-(Methoxycarbonyl)-L-tert-leucine (CAS: 162537-11-3) is a white crystalline chiral amino acid derivative combining an L-tert-leucine core with a methoxycarbonyl-protected amine. It is a key intermediate for the efficient synthesis of HIV protease inhibitors, most notably atazanavir, where the bulky tert-butyl side chain and protected amine are built into the active structure. The compound also serves as a reference material for atazanavir related-compound analysis. Material is controlled for enantiomeric consistency to support asymmetric API synthesis. Customers procure it for antiretroviral API programs where consistent stereochemical quality is essential.

For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.

REQUEST A QUOTE

Product Inquiry — Popup Form